News – Page 341
-
ResearchFirst isolation of stable solid-state bismuth radical
Elusive paramagnetic species has been characterised by both EPR and x-ray crystallography
-
Business
AstraZeneca sells off drugs to streamline portfolio
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus
-
NewsUS government science institute's one time police chief linked to campus meth lab
Explosion injuring a member of the National Institute of Standards and Technology’s security force uncovered methamphetamine production
-
Research
Stone 'blueprinting' to tackle heritage thefts
Technique could provide a means of tracing stolen, unmarked stones
-
Business
Lightweight composites drive Solvay to buy Cytec
$5.5bn deal launches Solvay into aerospace materials business
-
ResearchHungry Ghost festival behind annual air quality decline in Singapore
Findings suggest that regulatory monitoring may be required
-
ResearchKirigami graphene makes microscale devices
Ancient Japanese folding and cutting art form used to create functional springs and hinges
-
NewsBig business backs White House on climate change
Top US companies including Google, Apple and Coca-Cola pledge at least $140 billion in new low-carbon investments
-
ResearchPhilae poses comet chemistry conundrum
Historic mass spectra find 67P carries precursors to key biomolecules, but instruments detect different ones
-
News
Switzerland R&D spending falls after Horizon 2020 cash freeze
Referendum vote to limit EU immigration has led to national research spending being cuts of 7%
-
NewsMalaria vaccine approval first marred by efficacy question mark
Low protection rates in trials and uncertainty over cost-effectiveness leave vaccine’s future up in the air
-
Business
Allergan steps away from generics with sale to Teva
$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and catapults Teva into global pharma top 10
-
ResearchAntifreeze polymer protects cells as they thaw
Simple synthetic polymer found to enhance cryopreservation of red blood cells by inhibiting ice crystal growth
-
Business
Biogen to develop gene therapies with AGTC
$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases
-
Business
Celgene to buy immune-inflammatory specialist Receptos
$7.2bn deal further strengthens Celgene’s position in immunology
-
Business
Hikma boosts generics with Roxane buyout
Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market
-
ResearchZeolite packaging to fight durian fruit stench
Cheap odour-eating films can capture nasty smells and could soon find their way into clothing as well as food wrapping
-
NewsNew Horizons sees red over Pluto’s atmosphere
Reaction of methane breakdown products are responsible for the dwarf planet’s rosy hue
-
NewsUS government uncovers safety failings at nuclear lab
Los Alamos National Laboratory’s safety culture put under the microscope by Department of Energy
-
ResearchBattery buffer takes the strain
Unconventional layered oxide that counteracts volume expansion in electrodes could help batteries last longer